Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 22Breast Neoplasms 21Polycystic Ovary Syndrome 12Carcinoma, Non-Small-Cell Lung 11Colorectal Neoplasms 10Lung Neoplasms 8Endometrial Neoplasms 7Pancreatic Neoplasms 6Neoplasms 6Glioblastoma 5Rectal Neoplasms 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Insulin Resistance 4Adenocarcinoma of Lung 4Adenocarcinoma 4Uterine Cervical Neoplasms 3Leukoplakia, Oral 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Obesity 2Neoplasm Metastasis 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Hyperandrogenism 2Esophageal Neoplasms 2Erythroplasia 2Endometrial Hyperplasia 2Diabetes Mellitus 2Colonic Neoplasms 2

Interventions

YF 476 2Specimen Handling 2Aspirin 2obeticholic acid 1Ursodeoxycholic Acid 1Sunitinib 1Spectrum Analysis 1Radiofrequency Ablation 1Proflavine 1Photochemotherapy 1Metformin 1Itraconazole 1Gastroscopy 1Esomeprazole 1Endoscopy, Digestive System 1Endoscopy 1Endoscopic Mucosal Resection 1Dihematoporphyrin Ether 1Dexlansoprazole 1Cetuximab 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Barrett Esophagus × Metformin × Clear all
NCT01447927 2014-07-21

Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus

National Cancer Institute (NCI)

Phase 2 Completed
93 enrolled 10 charts
Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡